With 21.9% CAGR, Human Microbiome Market to US$ 1,827.2 Million by 2027 | Healthcare Industry Report by IMARC Group
Human microbiomes are a group of microorganisms, including bacteria, bacteriophage, fungi, protozoa, and viruses present on and within the body. They reside inside various human tissues and biofluids, including skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, saliva, oral mucosa, conjunctiva, and gastrointestinal tracts. The human microbiome help digest food, regulate the immune system, protect against various bacteria that cause diseases, and produce vitamin B12, thiamine, and riboflavin that help in blood coagulation. Consequently, they are used in prebiotics, diagnostic devices, probiotics, medical drugs, and supplements. Apart from this, the human microbiome is further utilized to treat metabolic, gastrointestinal, neurological, central nervous, and autoimmune disorders. Market Overview: The global human microbiome market size reached US$ 558.5 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,827.2 Million by 2027, exhibiting...